Scarica l'app Stockscreener
61.00
1.43%
0.86
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MNST Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$60.14
Aprire:
$58.81
Volume 24 ore:
8.26M
Relative Volume:
1.42
Capitalizzazione di mercato:
$58.44B
Reddito:
$7.49B
Utile/perdita netta:
$1.51B
Rapporto P/E:
38.36
EPS:
1.59
Flusso di cassa netto:
$1.62B
1 W Prestazione:
+1.58%
1M Prestazione:
+4.72%
6M Prestazione:
+12.67%
1 anno Prestazione:
+10.51%
Intervallo 1D:
$58.62
$61.83
Intervallo di 1 settimana:
$58.62
$61.83
Portata 52W:
$43.32
$61.83
Monster Beverage Corp Stock (MNST) Company Profile
Nome
Monster Beverage Corp
Settore
Industria
Telefono
909-739-6200
Indirizzo
1 MONSTER WAY, CORONA, CA
Confronta MNST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MNST
Monster Beverage Corp
|
61.00 | 58.44B | 7.49B | 1.51B | 1.62B | 1.59 |
|
KO
Coca Cola Co
|
70.52 | 308.40B | 46.89B | 10.78B | -928.00M | 2.50 |
|
PEP
Pepsico Inc
|
130.44 | 183.38B | 91.52B | 9.37B | 7.27B | 6.80 |
|
KOF
Coca Cola Femsa S A B De C V Adr
|
92.92 | 19.66B | 15.24B | 1.29B | 0 | 6.1525 |
|
PRMB
Primo Brands Corp
|
31.94 | 12.43B | 0 | 0 | 0 | 0.00 |
Monster Beverage Corp Stock (MNST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-09 | Reiterato | JP Morgan | Neutral |
| 2025-05-09 | Reiterato | Morgan Stanley | Overweight |
| 2025-05-09 | Reiterato | Piper Sandler | Neutral |
| 2025-05-09 | Reiterato | TD Cowen | Hold |
| 2025-05-09 | Reiterato | UBS | Neutral |
| 2025-05-05 | Reiterato | Wells Fargo | Overweight |
| 2025-05-02 | Reiterato | JP Morgan | Neutral |
| 2025-04-25 | Reiterato | BofA Securities | Buy |
| 2025-04-23 | Reiterato | Truist | Sell |
| 2025-04-17 | Reiterato | UBS | Neutral |
| 2025-04-16 | Reiterato | Jefferies | Buy |
| 2025-04-14 | Reiterato | Citigroup | Buy |
| 2025-04-02 | Reiterato | Wells Fargo | Overweight |
| 2025-03-03 | Reiterato | UBS | Neutral |
| 2025-02-28 | Reiterato | Citigroup | Buy |
| 2025-02-28 | Reiterato | Deutsche Bank | Buy |
| 2025-02-28 | Reiterato | JP Morgan | Neutral |
| 2025-02-28 | Reiterato | Morgan Stanley | Overweight |
| 2024-12-19 | Reiterato | Exane BNP Paribas | Underperform |
| 2024-12-06 | Iniziato | Needham | Hold |
| 2024-11-12 | Reiterato | Argus | Buy |
| 2024-11-11 | Reiterato | TD Cowen | Hold |
| 2024-11-08 | Reiterato | Deutsche Bank | Buy |
| 2024-11-08 | Reiterato | JP Morgan | Neutral |
| 2024-11-08 | Reiterato | Stifel | Buy |
| 2024-11-08 | Reiterato | UBS | Neutral |
| 2024-11-05 | Reiterato | Wells Fargo | Overweight |
| 2024-11-04 | Reiterato | JP Morgan | Neutral |
| 2024-10-15 | Reiterato | BofA Securities | Buy |
| 2024-10-07 | Reiterato | UBS | Neutral |
| 2024-08-12 | Reiterato | ROTH MKM | Neutral |
| 2024-08-09 | Reiterato | Truist | Sell |
| 2024-08-08 | Reiterato | Citigroup | Buy |
| 2024-08-08 | Reiterato | Deutsche Bank | Buy |
| 2024-08-08 | Reiterato | JP Morgan | Neutral |
| 2024-08-08 | Reiterato | Jefferies | Buy |
| 2024-08-08 | Reiterato | Piper Sandler | Neutral |
| 2024-08-08 | Reiterato | RBC Capital Mkts | Outperform |
| 2024-08-08 | Reiterato | UBS | Neutral |
| 2024-08-08 | Reiterato | Wells Fargo | Overweight |
| 2024-07-23 | Reiterato | JP Morgan | Neutral |
| 2024-07-15 | Reiterato | TD Cowen | Hold |
| 2024-07-10 | Reiterato | BofA Securities | Buy |
| 2024-07-10 | Reiterato | Citigroup | Buy |
| 2024-06-25 | Reiterato | Wells Fargo | Overweight |
| 2024-06-24 | Iniziato | Exane BNP Paribas | Underperform |
| 2024-06-17 | Reiterato | Stifel | Buy |
| 2024-05-03 | Reiterato | Morgan Stanley | Overweight |
| 2024-05-03 | Reiterato | Piper Sandler | Neutral |
| 2024-05-03 | Reiterato | UBS | Neutral |
| 2024-01-17 | Reiterato | BMO Capital Markets | Market Perform |
| 2024-01-17 | Reiterato | Citigroup | Buy |
| 2024-01-17 | Reiterato | Goldman | Buy |
| 2024-01-17 | Reiterato | JP Morgan | Overweight |
| 2023-11-20 | Reiterato | Piper Sandler | Neutral |
| 2023-11-20 | Reiterato | ROTH MKM | Neutral |
| 2023-11-13 | Iniziato | Jefferies | Buy |
| 2023-11-03 | Reiterato | Wells Fargo | Overweight |
| 2023-10-31 | Reiterato | JP Morgan | Overweight |
| 2023-10-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-10-23 | Reiterato | Deutsche Bank | Buy |
| 2023-10-05 | Aggiornamento | CFRA | Hold → Buy |
| 2023-08-14 | Iniziato | HSBC Securities | Buy |
| 2023-08-10 | Reiterato | ROTH MKM | Neutral |
| 2023-08-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-08-04 | Reiterato | UBS | Neutral |
| 2023-07-31 | Reiterato | Stifel | Buy |
| 2023-07-25 | Reiterato | Evercore ISI | Outperform |
| 2023-06-08 | Iniziato | Piper Sandler | Neutral |
| 2023-05-08 | Reiterato | BMO Capital Markets | Market Perform |
| 2023-05-08 | Reiterato | ROTH MKM | Neutral |
| 2023-05-05 | Reiterato | BofA Securities | Buy |
| 2023-05-05 | Reiterato | Citigroup | Buy |
| 2023-05-05 | Reiterato | Deutsche Bank | Buy |
| 2023-05-05 | Reiterato | Goldman | Buy |
| 2023-05-05 | Reiterato | JP Morgan | Overweight |
| 2023-05-05 | Reiterato | Morgan Stanley | Overweight |
| 2023-05-05 | Reiterato | RBC Capital Mkts | Outperform |
| 2023-05-05 | Reiterato | Truist | Buy |
| 2023-05-05 | Reiterato | UBS | Neutral |
| 2023-05-05 | Reiterato | Wells Fargo | Overweight |
| 2023-04-06 | Reiterato | UBS | Neutral |
| 2023-04-06 | Reiterato | Wedbush | Neutral |
| 2023-03-06 | Aggiornamento | Redburn | Neutral → Buy |
| 2023-03-01 | Reiterato | BMO Capital Markets | Market Perform |
| 2023-03-01 | Downgrade | CFRA | Buy → Hold |
| 2023-03-01 | Reiterato | Citigroup | Buy |
| 2023-03-01 | Reiterato | JP Morgan | Overweight |
| 2023-03-01 | Reiterato | Morgan Stanley | Overweight |
| 2023-03-01 | Reiterato | Truist | Buy |
| 2023-03-01 | Reiterato | Wells Fargo | Overweight |
| 2023-02-17 | Iniziato | Citigroup | Buy |
| 2023-01-18 | Reiterato | BMO Capital Markets | Market Perform |
| 2023-01-18 | Reiterato | Evercore ISI | Outperform |
| 2022-11-04 | Reiterato | BofA Securities | Buy |
| 2022-11-04 | Reiterato | Morgan Stanley | Overweight |
| 2022-11-04 | Reiterato | RBC Capital Mkts | Outperform |
| 2022-11-04 | Reiterato | UBS | Neutral |
| 2022-11-04 | Reiterato | Wells Fargo | Overweight |
| 2022-11-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-10-11 | Iniziato | Wedbush | Neutral |
| 2022-08-05 | Reiterato | RBC Capital Mkts | Outperform |
| 2022-07-05 | Iniziato | ROTH Capital | Neutral |
| 2022-06-06 | Reiterato | Morgan Stanley | Overweight |
| 2022-05-18 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2022-02-25 | Reiterato | Citigroup | Buy |
| 2022-02-25 | Reiterato | Cowen | Market Perform |
| 2022-02-25 | Reiterato | Deutsche Bank | Buy |
| 2022-02-25 | Reiterato | Guggenheim | Buy |
| 2022-02-25 | Reiterato | JP Morgan | Neutral |
| 2022-02-17 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-11-01 | Iniziato | Redburn | Neutral |
| 2021-10-13 | Downgrade | Jefferies | Buy → Hold |
| 2021-07-23 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-05-07 | Reiterato | Truist | Buy |
| 2021-02-26 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-01-20 | Iniziato | Bernstein | Mkt Perform |
| 2021-01-15 | Reiterato | Citigroup | Neutral |
| 2021-01-15 | Reiterato | Deutsche Bank | Buy |
| 2021-01-15 | Reiterato | Truist | Buy |
| 2020-12-10 | Reiterato | Morgan Stanley | Overweight |
| 2020-12-08 | Iniziato | Wells Fargo | Overweight |
| 2020-11-17 | Aggiornamento | UBS | Sell → Neutral |
| 2020-11-03 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-20 | Reiterato | Guggenheim | Buy |
| 2020-05-28 | Reiterato | Stifel | Buy |
| 2020-05-11 | Downgrade | Citigroup | Buy → Neutral |
| 2020-05-05 | Reiterato | Guggenheim | Buy |
| 2020-04-16 | Ripresa | BofA/Merrill | Buy |
| 2020-04-01 | Ripresa | Goldman | Buy |
| 2020-03-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-03-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-10-17 | Downgrade | Cowen | Outperform → Market Perform |
| 2019-10-02 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-08-08 | Reiterato | BMO Capital Markets | Market Perform |
| 2019-08-08 | Reiterato | Morgan Stanley | Equal-Weight |
| 2019-08-08 | Reiterato | UBS | Sell |
| 2019-04-01 | Downgrade | Macquarie | Outperform → Neutral |
| 2019-03-28 | Reiterato | Morgan Stanley | Equal-Weight |
Mostra tutto
Monster Beverage Corp Borsa (MNST) Ultime notizie
Monster Beverage Corporation (NASDAQ:MNST) Q1 2025 Earnings Call Transcript - Insider Monkey
Monster Beverage: The Big Boy Seems To Be Struggling (NASDAQ:MNST) - Seeking Alpha
Monster Beverage sees strong April sales growth with robust Q2 outlook - MSN
Balyasny Asset Management L.P. Has $15.62 Million Holdings in Monster Beverage Co. (NASDAQ:MNST) - MarketBeat
Baird Financial Group Inc. Purchases 27,272 Shares of Monster Beverage Co. (NASDAQ:MNST) - MarketBeat
Mercer Global Advisors Inc. ADV Sells 6,607 Shares of Monster Beverage Co. (NASDAQ:MNST) - MarketBeat
Morgan Stanley Raises Price Target for Monster Beverage (MNST) | - GuruFocus
Morgan Stanley Boosts Target for Monster Beverage (MNST) to $65 - GuruFocus
Monster Beverage (MNST) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Monster Beverage (NasdaqGS:MNST) Reports Flat Sales But Slight EPS Growth - Yahoo
Monster Beverage (MNST) Rebounds with Strong April Sales - GuruFocus
Monster's Q1 sales fall flat, but April fuels analyst optimism - MSN
Morgan Stanley Raises Price Target for Monster Beverage (MNST) | MNST Stock News - GuruFocus
Monster's Q1 sales fall flat, but April fuels analyst optimism (MNST:NASDAQ) - Seeking Alpha
Monster Beverage Stock Trades at All-Time High on Strong April Sales - MSN
Monster Beverage Faces Improving Margin Trends After Q1 Revenue Miss, Deutsche Bank Says - marketscreener.com
Monster Beverage's Margins Are Looking Healthier Despite Recent Hiccups - Finimize
Piper Sandler Raises Price Target for Monster Beverage (MNST) | MNST Stock News - GuruFocus
Monster: Low-Energy Q1 Sees Net Sales Drop, Alcohol Drag - BevNET.com
Morgan Stanley Boosts Target for Monster Beverage (MNST) to $65 | MNST Stock News - GuruFocus
Monster Beverage (MNST) Reports Lower Q1 Revenue Amid Various Challenges | MNST Stock News - GuruFocus
UBS Adjusts Price Target for Monster Beverage (MNST) Amid Strong Q2 Performance | MNST Stock News - GuruFocus
Monster Beverage (MNST) Sees Price Target Boost from Piper Sandl - GuruFocus
Monster Beverage price target raised to $63 from $62 at UBS - TipRanks
Deutsche Bank Adjusts Monster Beverage Price Target to $68 From $66, Maintains Buy Rating - marketscreener.com
Monster Beverage Corporation (MNST) Earnings: 1Q25 Key Numbers - AlphaStreet
Morgan Stanley Raises Price Target on Monster Beverage to $65 From $60, Keeps Overweight Rating - marketscreener.com
Monster Beverage Co. (NASDAQ:MNST) Shares Bought by Aptus Capital Advisors LLC - MarketBeat
Crestline Management LP Acquires 5,913 Shares of Monster Beverage Co. (NASDAQ:MNST) - MarketBeat
Monster Beverage Posts Surprise Fall In Quarterly Net Sales - European Supermarket Magazine
Monster Beverage Corp SEC 10-Q Report - TradingView
Monster Beverage Posts Surprise Fall In Quarterly Net Sales On Choppy Demand - checkout.ie
Monster Beverage Q1 2025 Earnings Call Transcript - MarketBeat
Monster Beverage Corp (MNST) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth - GuruFocus
The Manufacturers Life Insurance Company Sells 8,663 Shares of Monster Beverage Co. (NASDAQ:MNST) - MarketBeat
Monster's CEO: 'We Don't Always Win' On Hedging—As Aluminum Tariffs Bite Into Q2 Margins - Benzinga
Earnings call transcript: Monster Beverage misses Q1 2025 revenue forecast By Investing.com - Investing.com India
Monster Beverage (MNST) Sees Operating Income Rise Amid Q1 Sales Dip - GuruFocus
Monster Beverage Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Monster Beverage posts surprise fall in quarterly net sales on choppy demand - Reuters
Earnings call transcript: Monster Beverage misses Q1 2025 revenue forecast - Investing.com
Monster Beverage: Q1 Earnings Snapshot - The Washington Post
Monster (NASDAQ:MNST) Misses Q1 Revenue Estimates - Yahoo Finance
Monster Beverage sales slump on weak demand for alcohol beverages - MSN
Monster Beverage sales slump on weak demand for alcohol beverages (MNST:NASDAQ) - Seeking Alpha
Monster Beverage shares fall as Q1 results miss estimates By Investing.com - Investing.com Canada
Monster Beverage shares fall as Q1 results miss estimates - Investing.com
Monster Beverage earnings missed by $0.01, revenue fell short of estimates - Investing.com
Monster Beverage Corp Q1 2025 Earnings: EPS at $0.45 and Revenue at $1.85 Billion, Both Miss Estimates - GuruFocus
Monster Beverage Reports 2025 First Quarter Results - The Manila Times
Monster Beverage Q1 Adjusted Earnings Rise, Revenue Drops - marketscreener.com
Monster Beverage Corp Azioni (MNST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.05%
1.18%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):